Aisling Capital Management as of Dec. 31, 2023
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 16 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 73.1 | $245M | 6.1M | 40.37 | |
| Verona Pharma Sponsored Ads (VRNA) | 6.6 | $22M | 1.1M | 19.88 | |
| Syndax Pharmaceuticals (SNDX) | 6.6 | $22M | 1.0M | 21.61 | |
| Biomea Fusion (BMEA) | 3.5 | $12M | 799k | 14.52 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.5 | $8.4M | 965k | 8.75 | |
| Monte Rosa Therapeutics (GLUE) | 2.5 | $8.3M | 1.5M | 5.65 | |
| Nuvation Bio Com Cl A (NUVB) | 1.1 | $3.8M | 2.5M | 1.51 | |
| Spruce Biosciences (SPRB) | 1.1 | $3.5M | 1.2M | 2.93 | |
| Poseida Therapeutics I (PSTX) | 1.0 | $3.5M | 1.0M | 3.36 | |
| Marker Therapeutics (MRKR) | 0.5 | $1.7M | 314k | 5.50 | |
| Elevation Oncology (ELEV) | 0.5 | $1.5M | 2.8M | 0.54 | |
| Reneo Pharmaceuticals (RPHM) | 0.4 | $1.4M | 886k | 1.60 | |
| Avrobio Ord (AVRO) | 0.4 | $1.4M | 1.0M | 1.36 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $456k | 435k | 1.05 | |
| Viracta Therapeutics (VIRX) | 0.0 | $165k | 289k | 0.57 | |
| Atreca Cl A Com (BCEL) | 0.0 | $51k | 388k | 0.13 |
